Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference
07 août 2024 08h00 HE
|
Compass Therapeutics
BOSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
Compass Therapeutics to Present at the 13th Annual Wedbush PacGrow Healthcare Conference
02 août 2022 08h00 HE
|
Compass Therapeutics
BOSTON, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...
Surface Oncology to Participate in the 2022 Wedbush PacGrow Healthcare Conference
01 août 2022 16h30 HE
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Prevail Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Conference
05 août 2020 16h31 HE
|
Prevail Therapeutics
NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with...
Surface Oncology to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
05 août 2020 11h59 HE
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Aptinyx to Present at the 2019 Wedbush PacGrow Healthcare Conference
06 août 2019 08h33 HE
|
Aptinyx Inc.
EVANSTON, Ill., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...
Aidikoff, Uhl & Bakhtiari Announces the Filing of a FINRA Arbitration Claim Seeking More than $1.1 Million On Behalf Of Former Customer of Wedbush Securities, Inc. broker Mark Heiden
12 sept. 2016 11h00 HE
|
Aidikoff, Uhl & Bakhtiari
BEVERLY HILLS, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Aidikoff, Uhl & Bakhtiari announces the filing of a FINRA arbitration seeking more than $1.1 million and its continuing investigation of...
Fate Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference
10 août 2016 16h01 HE
|
Fate Therapeutics, Inc.
SAN DIEGO, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...
ZAGG Presenting at the Wedbush Securities 2015 California Dreamin’ Technology|Consumer Conference
23 nov. 2015 16h39 HE
|
ZAGG Inc
SALT LAKE CITY, Nov. 23, 2015 (GLOBE NEWSWIRE) -- ZAGG Inc (Nasdaq:ZAGG), a leading global mobile device accessories company, announced that Brad Holiday, chief financial officer, along with Kim...